Press Releases NEURONES

Equities

Market Closed - Euronext Paris Other stock markets 16:35:30 02/05/2024 BST			5-day change	1st Jan Change
45 ^EUR	+0.90%		-2.17%	+2.86%

03-07	Neurones: 11% growth in annual net income	CF
03-06	Neurones S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NEURONES : Letter to shareholders - april 2024	04-25	PU
NEURONES: Net profit (group share) up 11.5% in 2023	03-06	GL
NEURONES: Net profit (group share) up 11.5% in 2023	03-06	AQ
NEURONES: 11.1% organic growth in 2023	02-07	GL
NEURONES: Organic growth up 12.3% over the first nine months of the year	11-08	GL
NEURONES: Organic growth up 12.3% over the first nine months of the year	11-08	AQ
NEURONES : Letter to shareholders - october 2023	17/10/23	PU
NEURONES : 8.1% net profit in 1st half 2023	06/09/23	PU
NEURONES: 8.1% net profit in 1st half 2023	06/09/23	GL
NEURONES: 8.1% net profit in 1st half 2023	06/09/23	AQ
NEURONES : Organic growth up 12.9% in 1st half 2023	02/08/23	PU
NEURONES: Organic growth up 12.9% in 1st half 2023	02/08/23	GL
NEURONES: Organic growth up 12.9% in 1st half 2023	02/08/23	AQ
NEURONES : 2022 annual report - Universal Registration Document	08/06/23	PU
NEURONES: Organic growth up 15.1% in 1st quarter 2023	10/05/23	GL
NEURONES: Organic growth up 15.1% in 1st quarter 2023	10/05/23	AQ
NEURONES : Letter to shareholders - april 2023	23/03/23	PU
NEURONES : 7.8% net profit in 2022	08/03/23	PU
NEURONES: 7.8% net profit in 2022	08/03/23	GL
NEURONES: 7.8% net profit in 2022	08/03/23	AQ

No results for this search